Lixte Biotechnology Holdings Stock Alpha and Beta Analysis

LIXT Stock  USD 3.52  1.26  55.75%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Lixte Biotechnology Holdings. It also helps investors analyze the systematic and unsystematic risks associated with investing in Lixte Biotechnology over a specified time horizon. Remember, high Lixte Biotechnology's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Lixte Biotechnology's market risk premium analysis include:
Beta
4.36
Alpha
0.5
Risk
9.59
Sharpe Ratio
0.11
Expected Return
1.04
Please note that although Lixte Biotechnology alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., NYSE Composite index.) So in this particular case, Lixte Biotechnology did 0.50  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Lixte Biotechnology Holdings stock's relative risk over its benchmark. Lixte Biotechnology has a beta of 4.36  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Lixte Biotechnology will likely underperform. At this time, Lixte Biotechnology's Price Book Value Ratio is comparatively stable compared to the past year. Price Fair Value is likely to gain to 1.18 in 2024, whereas Enterprise Value Multiple is likely to drop (0.06) in 2024.
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Lixte Biotechnology Backtesting, Lixte Biotechnology Valuation, Lixte Biotechnology Correlation, Lixte Biotechnology Hype Analysis, Lixte Biotechnology Volatility, Lixte Biotechnology History and analyze Lixte Biotechnology Performance.

Lixte Biotechnology Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Lixte Biotechnology market risk premium is the additional return an investor will receive from holding Lixte Biotechnology long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Lixte Biotechnology. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Lixte Biotechnology's performance over market.
α0.50   β4.36

Lixte Biotechnology expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Lixte Biotechnology's Buy-and-hold return. Our buy-and-hold chart shows how Lixte Biotechnology performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Lixte Biotechnology Market Price Analysis

Market price analysis indicators help investors to evaluate how Lixte Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lixte Biotechnology shares will generate the highest return on investment. By understating and applying Lixte Biotechnology stock market price indicators, traders can identify Lixte Biotechnology position entry and exit signals to maximize returns.

Lixte Biotechnology Return and Market Media

The median price of Lixte Biotechnology for the period between Fri, Dec 29, 2023 and Thu, Mar 28, 2024 is 2.27 with a coefficient of variation of 12.15. The daily time series for the period is distributed with a sample standard deviation of 0.28, arithmetic mean of 2.3, and mean deviation of 0.2. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Is Lixte Biotechnology Holdings Inc Stock a Good Value - InvestorsObserver
01/29/2024
2
Lixte Biotechnology Announces Filing of First Patent Application Resulting from Collaboration with the Netherlands ... - The Globe and Mail
02/28/2024
3
LIXT Stock Earnings Lixte Biotech Hldgs Reported Results for Q4 2023
03/20/2024
4
Why Lixte Biotechnology Stock Is Soaring
03/27/2024

About Lixte Biotechnology Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Lixte or other stocks. Alpha measures the amount that position in Lixte Biotechnology has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2023 2024 (projected)
Dividend Yield0.0016130.001694
Price To Sales Ratio10.529.35

Lixte Biotechnology Upcoming Company Events

As portrayed in its financial statements, the presentation of Lixte Biotechnology's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Lixte Biotechnology's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Lixte Biotechnology's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Lixte Biotechnology. Please utilize our Beneish M Score to check the likelihood of Lixte Biotechnology's management manipulating its earnings.
3rd of April 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Build Portfolio with Lixte Biotechnology

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Lixte Biotechnology is a strong investment it is important to analyze Lixte Biotechnology's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Lixte Biotechnology's future performance. For an informed investment choice regarding Lixte Stock, refer to the following important reports:

Complementary Tools for Lixte Stock analysis

When running Lixte Biotechnology's price analysis, check to measure Lixte Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotechnology is operating at the current time. Most of Lixte Biotechnology's value examination focuses on studying past and present price action to predict the probability of Lixte Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lixte Biotechnology's price. Additionally, you may evaluate how the addition of Lixte Biotechnology to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Lixte Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Lixte Biotechnology technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Lixte Biotechnology trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...